Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Izervay
Pharma
Apellis expects sales of Syfovre to decline in Q1
Apellis plans to increase sales of GA treatment Syfovre by attracting more patients to the market, including via DTC ads starring Henry Winkler.
Kevin Dunleavy
Feb 28, 2025 3:05pm
Astellas, Mitsubishi Tanabe, Leqembi—Fierce Pharma Asia
Feb 14, 2025 9:51am
Astellas' Izervay wins key FDA label update after prior rejection
Feb 13, 2025 12:00pm
Astellas shifts investment focus to later-stage programs: exec
Feb 12, 2025 1:30pm
Merck, AstraZeneca, Astellas—Fierce Pharma Asia
Feb 7, 2025 9:00am
Astellas takes $760M charge, reveals slowdown for Izervay
Feb 5, 2025 3:22pm
